Skip to content
Independent analysis of NHS open data
PharmaInsight

Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide

Infections Antiviral drugs BNF 0503010BE
Data updated February 2026 Download CSV
1items

Dispensed in February 2026

1items

Rolling 12 months

£157

Net ingredient cost · February 2026

Figure 1. Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide: national items dispensed by month

0 0.5 1 Feb 2026 1 Feb 2026: 1

Source: NHSBSA Prescription Cost Analysis, to February 2026

Download CSV
Embed this chart

Free to reuse with the credit line above.

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £157.03
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, February 2026

The individual products dispensed under Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide this month.

Presentations of Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide, February 2026
Presentation BNF code Items Net ingredient cost
Symtuza 800mg/150mg/200mg/10mg tablets 0503010BEBBAAAA 1 £157

Source: NHSBSA Prescription Cost Analysis · to February 2026 OGL v3.0

Where Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide is dispensed

The regions and dispensing practices with the highest Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide with

Other medicines in the same BNF section, by prescribing volume.

Download this data

The monthly series for Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.